Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: Evidence for quinine resistance

American Journal of Tropical Medicine and Hygiene

Volumn 58, Issue 5, 1998, Pages 630-637

  Zalis, Mariano G ^a   Pang, Lorrin ^b   Silveira, Mariana S ^a   Milhous, Wilbur K ^c   Wirth, Dyann F ^d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b U States Med Research Unit Brazil   (Brazil)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ATOVAQUONE; CHLOROQUINE; FANSIDAR; HALOFANTRINE; PROGUANIL; QUININE;

ANTIMICROBIAL THERAPY; ARTICLE; BRAZIL; DNA DETERMINATION; DRUG SENSITIVITY; ENDEMIC DISEASE; GENE SEQUENCE; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SOUTHERN BLOTTING;

CAESALPINIA CILIATA; CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0031836529     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.58.630     Document Type: Article

References (37)

1. Marques AC, Gutierrez HC, 1994. Combate da malaria no Brasil: evolução, situação atual e perspectivas. Rev Soc Bras Med Trop 27: 91-108.
2. World Health Organization 1994. Bull World Health Organ 42: 309-324.
3. Person GW, 1991. Malaria: Obstacles and Opportunities. Oaks SC, Mitchell VS, eds. Washington, DC: National Academy Press, 345-356.
4. Andrade JG, Andrade ALS, Araujo ESO, Oliveira, RM, Silva, SA, Martelli, CMT, Zucker F, 1992. A randomized clinical trial with high dose of chloroquine for treatment of Plasmodium falciparum malaria in Brazil. Rev Inst Med Trop Sao Paulo 34: 467-473.
5. Couto AA, Calvosa VS, Lima JE, Souza JM, 1993. Evolução da resistencia in vitro do Plasmodium falciparum a anti maláricos em area de prospecçãao de ouro no Estado do Amapá, entre 1983 e 1990. Rev Soc Bras Med Trop 26: 215-220.
6. Peterson DS, Di Santi SM, Povoa M, Calvosa VS, Rosario V, Wellems T, 1991. Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian amazon. Am J Trop Med Hyg 45: 492-497.
7. Alencar FEC, Cerutti C Jr, Durlacher RR, Boulos M, Alves FP, Milhous M, Pang LW, 1997. Treatment of uncomplicated malaria with a combination of atovaquone plus proguanil in Brazilian adults. J Infect Dis 175: 1544-1547.
8. Olliaro PL, Goldberg DE, 1995. The Plasmodium digestive vacuole: metabolic headquarters and choice drug target. Parasitol Today 11: 294-297.
9. Su X-Z, Kirkman LA, Fujioka H, Wellems TE, 1997. Complex polymorphisms in an ∼330KDa protein are linked to chloroquine-resistant P. falciparum in southeast Asia and Africa. Cell 91: 593-603.
10. Rubio JP, Cowman AF, 1996. The ATP-binding cassette (ABC) gene. Parasitol Today 12: 135-140.
11. Karcz S, Cowman AF, 1991. Similarities and differences between the multidrug resistance phenotype of mammalian tumor cells and chloroquine resistance in Plasmodium falciparum. Exp Parasitol 73: 233-240.
12. Wilson CM, Serrano AE, Walsey A, Bogenschutz MP, Shankar AH, Wirth DF 1989. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum Science 244: 1184-1186.
13. Foote SJ, Thompson JK, Cowman AF, Kemp DJ, 1989. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57: 921-930.
14. Wilson CM, Volkman SK, Thaithong S, Martyin SK, Milhous SK, Wirth DF, 1994. Amplification of pfmdr1 associated with mefloquine and halofantrine resistant Plasmodium falciparum in Thailand. Mol Biochem Parasitol 57: 151-160.
15. Barnes DA, Foote SJ, Galatis D, Kemp DJ, Cowman AF, 1992. Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increase sensitivity to mefloquine in Plasmodium falciparum. EMBO J 11: 3067-3075.
16. Cowman AF, Galatis D, Thompson JK, 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci USA 91: 1143-1147.
17. Peel SA, Bright P, Yount B, Handy J, Baric RS, 1994. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the p-glycoprotein gene homologue (pfmdr) of Plasmodium falciparum in vitro. Am J Trop Med Hyg 51: 648-658.
18. Trager WM, Jensen JB, 1976. Human malaria parasites in continuous culture culture. Science 193: 673-675.
19. Oduola AMJ, Milhous WK, Weatherly NF, Bandre JH, Desjardins RE, 1988. Plasmodium falciparum induction of resistance to mefloquine cloned strains of continuos drug exposure in vitro. Exp Parasitol 67: 354-360.
20. Canfield CJ, Pudney M, Gutteridget WE, 1995. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp Parasitol 80: 373-381.
21. Brossi A, Venuogopalan B, Dominguez Gerpe L, Yen HLC, Flippen-Anderson JL, Buchs P, Luo XD, Milhous WK, Peters W, 1988. Artheeter, a new antimalarial drug: synthesis and antimalarial properties. J Med Chem 31: 645-650.
22. Surrey AR, Hammer HF, 1946. Some 7-substituted 4-amino-quinoline derivatives. J Am Soc Chem 68: 113-116.
23. Schmidt H, Crosby R, Rasco J, Vaughan D, 1978. Antimalarial activities of various 9-phenanthrenemethanols with special attention to WR-122,455 and WR-171,669t. Antimicrob Agents Chemother 14: 292-314.
24. Ohnmacht C, Patfl JA, Lijtz RE, 1971. Antimalarials. 7.Bis(trifluoromethyl)-a-(2-piperidyl)-4-quinolinernethanols. J Med Chem 14: 926-928.
25. Looareesuwan S, Vanijanonta, Viravan C, Wilairatana P, Lassere R, Canfield C, Kyle DE, Webster HK, 1994. Randomized trial of mefloquine-tetracycline and quinine-tetracycline for acute uncomplicated malaria. Acta Trop 57: 47-53.
26. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, 1979. Quantitative assessment of antimalarial activity in vitro by semiautomated microdilution technique. Antimicrob Agent Chemother 16: 710-718.
27. Le Bras J, Deloron P, 1983. In vitro study of drug sensitivity of Plasmodium falciparum: evaluation of a new semi-microtest. Am J Trop Med Hyg 32: 447-451.
28. Wooden J, Gould EE, Paul AT, Sibley CH, 1992. Plasmodium falciparum: a simple polymerase chain reaction method for differentiating strains. Exp Parasitol 75: 207-212.
29. World Health Organization, 1991. Basic Malaria Microscopy. Part I: Learner's Guide. Geneva: WHO.
30. Di Santi SM, Camargo Neves VLF, Boulos M, Dutra AP, Ramos AMSV, Santos M 1988. Avaliação da Resposta do Plasmodium falciparum a cloroquina, quinino, e mefloquina. Rev Inst Med Trop Sao Paulo 30: 147-152.
31. Rieckmann KH, Lopes-Antuano FJ, 1971. Chloroquine resistance of Plasmodium falciparum in Brazil detected by a simple in vitro method. Bull World Health Organ 45: 157-167.
32. Basco LK, Ramiliarisoa O, Le Bras J, 1995. In vitro activity of atovaquone against the African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 53: 388-391.
33. Foote SJ, Kyle DE, Martin RK, Oduola AMI, Forsyth K, Kemp, DJ, Cowman AF, 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 255-258.
34. Volkman, SK, Cowman, AF, Wirth DF, 1995. Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of Plasmodium falciparum. Proc Natl Acad Sci USA 92: 8921-8925.
35. Basco LK, Le Bras J, Rhoades Z, Wilson CM, 1995. Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from sub-Saharan Africa. Mol Biochem Parasitol 74: 157-166.
36. Awad-EL-Karien FM, Miles MA, Warhurst DC, 1992. Chloroquine-resistant Plasmodium falciparum isolates from the Sudan lack two mutations in the pfmdr1 gene thought to be associated with chloroquine resistance. Trans R Soc Trop Med Hyg 86: 587-589.
37. Haruki K, Bray PG, Ward SA, Hommel M, Ritchie Y, 1994. Chloroquine resistance of Plasmodium falciparum: further evidence for a lack of association with mutations of the pfmdr1 gene. Trans R Soc Trop Med Hyg 88: 694.